Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Dilip Davda recommend to "Avoid" the IPO.
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 1 | 0 |
| % | 0.00 | 0.00 | 0.00 | 100.00 | 0.00 |
| Reviewer | Recommendation | Past Reviews |
|---|---|---|
| Dilip Davda | Avoid |  |
[Dilip Davda]
Pharmaceutical industries are a highly regulated sector. Currently, pharma shares are not fancied by investors. Recent listings of SME Pharma companies have disappointed investors with the poor debut. Considering aggressive pricing, there is no harm in giving this issue a miss.
Read detail review...Post Recommendation Manage Recommendations
Note:
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
